Plant ID: NPO27843
Plant Latin Name: Lycoris radiata
Taxonomy Genus: Lycoris
Taxonomy Family: Amaryllidaceae
NCBI TaxonomyDB:
228395
Plant-of-the-World-Online:
60455959-2
Unknown.
Georgia; South Africa; Nepal; United States; Seychelles; China; Japan
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Hydrolase | ACHE | Acetylcholinesterase | P22303 | CHEMBL220 |
Isomerase | TOP1 | DNA topoisomerase I | P11387 | CHEMBL1781 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 4.823E-07 | 8.682E-03 | CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 1.447E-06 | 1.050E-02 | CYP2C19, CYP2C9 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 2.121E-06 | 1.155E-02 | CYP2C19, CYP2C9 |
MF | GO:0003824; catalytic activity | GO:0008392; arachidonic acid epoxygenase activity | 4.370E-06 | 1.586E-02 | CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 6.746E-06 | 2.098E-02 | CYP2C19, CYP2C9 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 1.800E-05 | 4.901E-02 | CYP2C19, CYP2C9 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 3.175E-05 | 7.681E-02 | CYP2C19, CYP2C9 |
MF | GO:0005488; binding | GO:0020037; heme binding | 2.592E-04 | 2.565E-01 | CYP2C19, CYP2C9 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 4.047E-04 | 2.818E-01 | CYP2C19, CYP2C9 |
CC | GO:0016020; membrane | GO:0005789; endoplasmic reticulum membrane | 1.278E-02 | 1.000E+00 | CYP2C19, CYP2C9 |
CC | GO:0043226; organelle | GO:0043231; intracellular membrane-bounded organelle | 2.667E-02 | 1.000E+00 | ACHE, CYP2C19, CYP2C9, TOP1 |
CC | GO:0044464; cell part | GO:0036464; cytoplasmic ribonucleoprotein granule | 3.777E-02 | 1.000E+00 | TOP1 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 1.216E-05 | 1.216E-04 | CYP2C9, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 5.651E-05 | 2.336E-04 | CYP2C9, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 7.007E-05 | 2.336E-04 | CYP2C9, CYP2C19 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 1.851E-04 | 3.702E-04 | CYP2C9, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 9.910E-05 | 2.478E-04 | CYP2C9, CYP2C19 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 1.294E-02 | 2.074E-02 | CYP2C9 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 2.116E-02 | 2.202E-02 | CYP2C9, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.452E-02 | 2.074E-02 | CYP2C9 |
09150 Organismal Systems | 09156 Nervous system | hsa04725 | Cholinergic synapse | 2.202E-02 | 2.202E-02 | ACHE |
09100 Metabolism | 09103 Lipid metabolism | hsa00564 | Glycerophospholipid metabolism | 1.887E-02 | 2.202E-02 | ACHE |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | CYP2C9; |